Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment.

Shah SH, de Lemos JA.

JAMA. 2009 Jul 1;302(1):92-3. doi: 10.1001/jama.2009.949. No abstract available.

PMID:
19567447
2.

C-reactive protein and cardiovascular disease: differences between humans and mice.

Jeppesen J, Asferg C.

Hypertension. 2010 Jul;56(1):e15; author reply e16. doi: 10.1161/HYPERTENSIONAHA.110.155077. No abstract available.

3.

Studies examine inflammatory biomarker in prevention and prediction of heart disease.

Mitka M.

JAMA. 2009 Jan 7;301(1):23-4. doi: 10.1001/jama.2008.876. No abstract available.

PMID:
19126804
4.

C-reactive protein and cardiovascular disease risk: still an unknown quantity?

Davey Smith G, Timpson N, Lawlor DA.

Ann Intern Med. 2006 Jul 4;145(1):70-2. No abstract available.

PMID:
16818931
5.

Is pentraxin 3 a cardiovascular marker in patients with chronic Chagas disease?

Lidani KC, Beltrame MH, Luz PR, Sandri TL, Nisihara RM, de Messias-Reaso IJ.

Int J Cardiol. 2015;190:233-5. doi: 10.1016/j.ijcard.2015.04.106. No abstract available.

6.

Novel cardiac markers.

Alder R.

Adv Nurse Pract. 2009 Jun;17(6):24-7; quiz 28. No abstract available.

PMID:
20000180
7.

C-reactive protein for cardiovascular risk assessment.

Kholeif MA.

Diabetes Care. 2005 Jul;28(7):1833-4. No abstract available.

PMID:
15983350
8.

[C-reactive protein as a coronary risk factor].

Garcia-Moll X, Guindo J, Carlos Kaski J.

Med Clin (Barc). 2001 Sep 22;117(8):303-8. Review. Spanish. No abstract available.

PMID:
11571124
9.

The impact of CCR5-Δ32 deletion on C-reactive protein levels and cardiovascular disease: Results from the Danish Blood Donor Study.

Dinh KM, Pedersen OB, Petersen MS, Sørensen E, Sørensen CJ, Kaspersen KA, Larsen MH, Møller B, Hjalgrim H, Ullum H, Erikstrup C.

Atherosclerosis. 2015 Sep;242(1):222-5. doi: 10.1016/j.atherosclerosis.2015.07.031.

PMID:
26222902
10.

Within-person variability in high-sensitivity C-reactive protein.

Bower JK, Lazo M, Juraschek SP, Selvin E.

Arch Intern Med. 2012 Oct 22;172(19):1519-21. doi: 10.1001/archinternmed.2012.3712. No abstract available.

11.

[C-reactive protein in the era of molecular medicine].

Torrabadella de Reynoso P, Pérez-Moltó H.

Med Clin (Barc). 2005 Dec 3;125(20):775-7. Spanish. No abstract available.

PMID:
16373027
12.

Inflammatory markers for risk stratification in primary prevention of cardiovascular disease: time for a 'multimarker' approach?

Ikonomidis I, Lekakis J, Kremastinos DT.

Thromb Haemost. 2006 Mar;95(3):397-8. No abstract available.

PMID:
16525564
13.

Summaries for patients. C-reactive protein and prediction of risk for cardiovascular disease in women.

[No authors listed]

Ann Intern Med. 2006 Jul 4;145(1):I19. No abstract available.

PMID:
16818922
14.

C-reactive protein and cardiovascular diseases--is it ready for primetime?

Lavie CJ, Milani RV, Verma A, O'Keefe JH.

Am J Med Sci. 2009 Dec;338(6):486-92. doi: 10.1097/MAJ.0b013e3181c61b66. Review.

PMID:
20010156
15.

Cardiovascular disease screening.

Duffy JY, Hameed AB.

Semin Perinatol. 2015 Jun;39(4):264-7. doi: 10.1053/j.semperi.2015.05.004. Review.

PMID:
26143091
16.

Novel biomarkers of cardiometabolic risk are associated with plasma glucose within non-diabetic range. The Brazilian Longitudinal Study of Adult Health - ELSA-Brasil.

Almeida-Pititto B, Ribeiro-Filho FF, Lotufo PA, Bensenor IM, Ferreira SR.

Diabetes Res Clin Pract. 2015 Jul;109(1):110-6. doi: 10.1016/j.diabres.2015.04.021.

PMID:
25958099
17.

C-reactive protein: adjunct to cardiovascular risk assessment.

Bahadursingh S, Beharry K, Maharaj K, Mootoo C, Sharma P, Singh J, Teelucksingh K, Tilluckdharry R.

West Indian Med J. 2009 Dec;58(6):551-5.

PMID:
20583681
18.

Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Discrimination for Incident Atherosclerotic Cardiovascular Disease Beyond Ambulatory Blood Pressure in Elderly Men.

Skoglund PH, Höijer J, Ärnlöv J, Zethelius B, Svensson P.

Hypertension. 2015 Sep;66(3):681-6; discussion 445. doi: 10.1161/HYPERTENSIONAHA.115.05717.

19.
20.

C-reactive protein for cardiovascular risk assessment in the metabolic syndrome: response to Kholeif et al.

Wong ND, Malik S.

Diabetes Care. 2005 Oct;28(10):2598-9. No abstract available.

PMID:
16186320
Items per page

Supplemental Content

Support Center